Dermatology
Oxsoralen® Supply Status Update We are currently experiencing a shortage of Oxsoralen® products due to an unanticipated change in supplier of the active ingredient. Valeant understands the importance of this drug to our patients and have been working diligently to resolve this issue as quickly as possible. We apologize for any inconvenience this shortage causes to you and your patients and are committed to obtaining the required approvals to re-supply these products rapidly. We will continue to provide updates as new information is received and anticipate that Oxsoralen-Ultra® will be available by the end of the first quarter of 2010. |
Valeant is working to build a significant dermatology portfolio through both acquisitions and internal growth. Our dermatology products help patients who are suffering from actinic keratoses and skin cancer (Efudex®), acne (Atralin® (tretinoin) Gel 0.05%), psoriasis (Oxsoralen-Ultra®) and those who are looking for a reduction in the appearance of scars (Dermatix™ Ultra), skin-aging (Kinerase®) and apparent pigmentation (Oxsoralen-Ultra®).
In October 2008, Valeant acquired Coria Laboratories, Ltd., and expanded its dermatology product portfolio with 17 prescription and OTC products. In December 2008, Valeant also acquired Dow Pharmaceutical Sciences, Inc., a specialty pharmaceutical company that added six products to its dermatology product pipeline including a recently FDA-approved product for acne, Acanya®, which was launched in March 2009.
In November 2008, Valeant acquired DermaTech Pty Ltd, an Australian specialty pharmaceutical company focused on dermatology products marketed throughout Australia and overseas. These products address common dermatological conditions such as dry, itchy or sensitive skin, acne, eczema, psoriasis, contact dermatitis, insect bites, skin warts and sunburn. This acquisition significantly expands Valeant's Australian specialty dermatology business and complements Valeant's current product portfolio.
For information about Valeant's dermatology products, please visit the individual product Web sites.
www.acanyagel.com
www.kinerase.com
www.atralingel.com
www.oxsoralen-ultra.com
www.cerave.com
www.efudex.com
www.dermatix.com.au
www.dermaveen.com.au